Healthfinch raised $7.5 million in its Series A round, the company announced today.

According to a release, the funds will be used to accelerate development of the Charlie software platform and speed up delivery to health systems.

“To this end, we’re moving beyond individual applications in favor of a robust Practice Automation Platform that can handle many more tasks beyond prescription refill requests, including visit planning, patient communication and much more,” Healthfinch CEO Jonathan Baran said in a statement.

Adams Street Partners led the round, which included participation from JumpStart Ventures, Chicago Ventures, OCA Ventures, Abundant Ventures and a private investor.

Charlie is used by health systems to automate, delegate and simplify the prescription refill request workflow.